TY - JOUR
T1 - Clinicopathologic features and prognostic factors for patients with colorectal cancer who are 75 years and older
AU - Zhao, Mingfang
AU - Liu, Hans
AU - Tang, Yanqing
AU - Meng, Xin
AU - Yu, Jun
AU - Wang, Qi
AU - Zhou, Qiao
AU - Leng, Sean X.
AU - Zhang, Haiyan
N1 - Funding Information:
We would like to thank the staffof the National Cancer Institute and their colleagues across the United States, and Information Management Services, Inc., all who have been involved with the SEER Program. This work was supported by the National Natural Science Foundation of China (Grant number: 81301838, 81271292) and funding from the Irma and Paul Milstein Medical Asian American Partnership (MMAAP) Foundation Program for Senior Health fellowship award, supported by the MMAAP Foundation (http://www. mmaapf.org) to Dr. Haiyan Zhang.
Publisher Copyright:
© Zhao et al.
PY - 2017
Y1 - 2017
N2 - Colorectal cancer (CRC) is common and can be considered as a disease of older adults. About one half of the cases were diagnosed in patients over 70 years of age. Decision-making about treatment for these older patients can be complicated by age-related physiological changes, impaired functional status, limited social support, and comorbidities. Many trials excluded patients using an upper limit of 75 years of age. Little is known about prognostic factors in patients who are over this age limit. In this study, we conducted an analysis in the Surveillance, Epidemiology and End Results (SEER) database to identify specific clinicopathologic features and prognostic factors for these vulnerable cancer patients (N= 293,616). They were predominantly female and had more stage I and II diseases in comparison to younger patients. On average, these patients had lower 5-year cause-specific mortality than younger patients (41.98% vs. 63.14%, P < 0.001). Gender, marital status, ethnicity, Tumor- Node-Metastasis stage, grade, histologic subtype, tumor size, status of surgery and radiotherapy were all independent prognostic factors for these elderly CRC patients. In particular, surgery could improve prognosis for all CRC patients with the exception of those who are older than 94 years old and with stage III disease. The identified clinicopathologic features and prognostic factor will help guide treatment decisionmaking for this oldest old subset of patients with CRC.
AB - Colorectal cancer (CRC) is common and can be considered as a disease of older adults. About one half of the cases were diagnosed in patients over 70 years of age. Decision-making about treatment for these older patients can be complicated by age-related physiological changes, impaired functional status, limited social support, and comorbidities. Many trials excluded patients using an upper limit of 75 years of age. Little is known about prognostic factors in patients who are over this age limit. In this study, we conducted an analysis in the Surveillance, Epidemiology and End Results (SEER) database to identify specific clinicopathologic features and prognostic factors for these vulnerable cancer patients (N= 293,616). They were predominantly female and had more stage I and II diseases in comparison to younger patients. On average, these patients had lower 5-year cause-specific mortality than younger patients (41.98% vs. 63.14%, P < 0.001). Gender, marital status, ethnicity, Tumor- Node-Metastasis stage, grade, histologic subtype, tumor size, status of surgery and radiotherapy were all independent prognostic factors for these elderly CRC patients. In particular, surgery could improve prognosis for all CRC patients with the exception of those who are older than 94 years old and with stage III disease. The identified clinicopathologic features and prognostic factor will help guide treatment decisionmaking for this oldest old subset of patients with CRC.
KW - Aged 75 years and over
KW - Clinicopathologic features
KW - Colorectal cancer
KW - Prognostic factors
UR - http://www.scopus.com/inward/record.url?scp=85030485550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030485550&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.20656
DO - 10.18632/oncotarget.20656
M3 - Article
C2 - 29108382
AN - SCOPUS:85030485550
SN - 1949-2553
VL - 8
SP - 80002
EP - 80011
JO - Oncotarget
JF - Oncotarget
IS - 45
ER -